| MAG |
MAG, GMA: Myelin-associated glycoprotein precursor |
HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
0.445 |
Evidence |
|
| C4BPB |
C4BPB: C4b-binding protein beta chain precursor |
SERPINA10 |
SERPINA10, ZPI, UNQ707/PRO1358: Protein Z-dependent protease inhibitor precursor |
0.445 |
Evidence |
|
| CD22 |
CD22, SIGLEC2: B-cell receptor CD22 precursor |
HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
0.445 |
Evidence |
|
| CD33 |
CD33, SIGLEC3: Myeloid cell surface antigen CD33 precursor |
SELL |
SELL, LNHR, LYAM1: L-selectin precursor |
0.445 |
Evidence |
|
| ATF1 |
ATF1: Cyclic AMP-dependent transcription factor ATF-1 |
SCYL3 |
SCYL3, PACE1: Protein-associating with the carboxyl-terminal domain of ezrin |
0.445 |
Evidence |
|
| ATF1 |
ATF1: Cyclic AMP-dependent transcription factor ATF-1 |
TLK1 |
TLK1, KIAA0137: Serine/threonine-protein kinase tousled-like 1 |
0.445 |
Evidence |
|
| ATF1 |
ATF1: Cyclic AMP-dependent transcription factor ATF-1 |
H1FX |
H1FX: Histone H1x |
0.445 |
Evidence |
|
| ATF1 |
ATF1: Cyclic AMP-dependent transcription factor ATF-1 |
MAP2K3 |
MAP2K3, MEK3, MKK3, PRKMK3: Dual specificity mitogen-activated protein kinase ki |
0.445 |
Evidence |
|
| RDBP |
RDBP, NELFE, RD: Negative elongation factor E |
PABPN1 |
PABPN1, PAB2, PABP2: Polyadenylate-binding protein 2 |
0.445 |
Evidence |
|
| RDBP |
RDBP, NELFE, RD: Negative elongation factor E |
HNRPF |
HNRPF: Heterogeneous nuclear ribonucleoprotein F |
0.445 |
Evidence |
|
| RDBP |
RDBP, NELFE, RD: Negative elongation factor E |
RBM15 |
RBM15, OTT: Putative RNA-binding protein 15 |
0.445 |
Evidence |
|
| RDBP |
RDBP, NELFE, RD: Negative elongation factor E |
RBM14 |
RBM14, SIP: RNA-binding protein 14 |
0.445 |
Evidence |
|
| RDBP |
RDBP, NELFE, RD: Negative elongation factor E |
ELAVL1 |
ELAVL1, HUR: ELAV-like protein 1 |
0.445 |
Evidence |
|
| RDBP |
RDBP, NELFE, RD: Negative elongation factor E |
KHDRBS1 |
KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate |
0.445 |
Evidence |
|
| RDBP |
RDBP, NELFE, RD: Negative elongation factor E |
SFRS2 |
SFRS2: Splicing factor, arginine/serine-rich 2 |
0.445 |
Evidence |
|
| RDBP |
RDBP, NELFE, RD: Negative elongation factor E |
SFRS10 |
SFRS10, TRA2B: Splicing factor, arginine/serine-rich 10 |
0.445 |
Evidence |
|
| RDBP |
RDBP, NELFE, RD: Negative elongation factor E |
EIF3S9 |
EIF3S9: Eukaryotic translation initiation factor 3 subunit 9 |
0.445 |
Evidence |
|
| RDBP |
RDBP, NELFE, RD: Negative elongation factor E |
BRPF1 |
BRPF1, BR140: Peregrin |
0.445 |
Evidence |
|
| RDBP |
RDBP, NELFE, RD: Negative elongation factor E |
RBMX |
RBMX, HNRPG, RBMXP1: Heterogeneous nuclear ribonucleoprotein G |
0.445 |
Evidence |
|
| IGFBP3 |
IGFBP3, IBP3: Insulin-like growth factor-binding protein 3 precursor |
BGN |
BGN: Biglycan precursor |
0.445 |
Evidence |
|
| HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
CD47 |
CD47, MER6: Leukocyte surface antigen CD47 precursor |
0.445 |
Evidence |
|
| HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
CD69 |
CD69: Early activation antigen CD69 |
0.445 |
Evidence |
|
| CAPN2 |
CAPN2, CANPL2: Calpain-2 catalytic subunit precursor |
FLNA |
FLNA, FLN, FLN1: Filamin-A |
0.445 |
Evidence |
|
| UBTF |
UBTF, UBF, UBF1: Nucleolar transcription factor 1 |
TGIF2 |
TGIF2: Homeobox protein TGIF2 |
0.445 |
Evidence |
|
| JUNB |
JUNB: Transcription factor jun-B |
ELF1 |
ELF1: ETS-related transcription factor Elf-1 |
0.445 |
Evidence |
|